OXAZOLIDONE DERIVATIVES AS PR MODULATORS

Compounds of the structure (I) are described, wherein R1, R2, R5, R6, V, X, Y, Z and Q are described herein, or a pharmaceutically acceptable salt, t automer, metabolite or prodrug thereof. These compounds are useful for treat ing a variety of hormone-related conditions including contraception, treatin g or preventing fibroids, endometriosis, dysfunctional bleeding, uterine lei omyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, provid ing hormone replacement therapy, stimulating food intake or synchronizing es trus.